Thrombotic and cardiovascular events are among the leading causes of death for patients
with polycythemia vera (PV), and thrombosis history is a key criterion for patient risk
stratification and treatment strategy. Little is known, however, about mechanisms of
thrombogenesis in patients with PV. This report provides an overview of thrombogenesis
pathophysiology in patients with PV and elucidates the roles of conventional and
nonconventional thrombotic risk factors. In addition to several conventional risk factors for …